Literature DB >> 16293762

DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling.

J Kirsty Millar1, Benjamin S Pickard, Shaun Mackie, Rachel James, Sheila Christie, Sebastienne R Buchanan, M Pat Malloy, Jennifer E Chubb, Elaine Huston, George S Baillie, Pippa A Thomson, Elaine V Hill, Nicholas J Brandon, Jean-Christophe Rain, L Miguel Camargo, Paul J Whiting, Miles D Houslay, Douglas H R Blackwood, Walter J Muir, David J Porteous.   

Abstract

The disrupted in schizophrenia 1 (DISC1) gene is a candidate susceptibility factor for schizophrenia, but its mechanistic role in the disorder is unknown. Here we report that the gene encoding phosphodiesterase 4B (PDE4B) is disrupted by a balanced translocation in a subject diagnosed with schizophrenia and a relative with chronic psychiatric illness. The PDEs inactivate adenosine 3',5'-monophosphate (cAMP), a second messenger implicated in learning, memory, and mood. We show that DISC1 interacts with the UCR2 domain of PDE4B and that elevation of cellular cAMP leads to dissociation of PDE4B from DISC1 and an increase in PDE4B activity. We propose a mechanistic model whereby DISC1 sequesters PDE4B in resting cells and releases it in an activated state in response to elevated cAMP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293762     DOI: 10.1126/science.1112915

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  241 in total

Review 1.  The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.

Authors:  Amy F T Arnsten
Journal:  Expert Rev Neurother       Date:  2010-10       Impact factor: 4.618

2.  Association of PDE4B polymorphisms and schizophrenia in Northwestern Han Chinese.

Authors:  Fanglin Guan; Chen Zhang; Shuguang Wei; Hongbo Zhang; Xiaomin Gong; Jiali Feng; Chengge Gao; Rong Su; Huanming Yang; Shengbin Li
Journal:  Hum Genet       Date:  2011-12-11       Impact factor: 4.132

3.  NMDA receptor regulates migration of newly generated neurons in the adult hippocampus via Disrupted-In-Schizophrenia 1 (DISC1).

Authors:  Takashi Namba; Guo-Li Ming; Hongjun Song; Chikako Waga; Atsushi Enomoto; Kozo Kaibuchi; Shinichi Kohsaka; Shigeo Uchino
Journal:  J Neurochem       Date:  2011-05-19       Impact factor: 5.372

4.  Identifying aberrant pathways through integrated analysis of knowledge in pharmacogenomics.

Authors:  Robert Hoehndorf; Michel Dumontier; Georgios V Gkoutos
Journal:  Bioinformatics       Date:  2012-06-17       Impact factor: 6.937

5.  Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.

Authors:  Mahomi Kuroiwa; Gretchen L Snyder; Takahide Shuto; Atsuo Fukuda; Yuchio Yanagawa; David R Benavides; Angus C Nairn; James A Bibb; Paul Greengard; Akinori Nishi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

6.  Genomic DISC1 Disruption in hiPSCs Alters Wnt Signaling and Neural Cell Fate.

Authors:  Priya Srikanth; Karam Han; Dana G Callahan; Eugenia Makovkina; Christina R Muratore; Matthew A Lalli; Honglin Zhou; Justin D Boyd; Kenneth S Kosik; Dennis J Selkoe; Tracy L Young-Pearse
Journal:  Cell Rep       Date:  2015-08-20       Impact factor: 9.423

Review 7.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

Review 8.  Spatial control of cAMP signalling in health and disease.

Authors:  Manuela Zaccolo
Journal:  Curr Opin Pharmacol       Date:  2011-10-13       Impact factor: 5.547

9.  An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signaling in schizophrenia.

Authors:  Bruce I Turetsky; Paul J Moberg
Journal:  Am J Psychiatry       Date:  2008-12-15       Impact factor: 18.112

Review 10.  Chromosome abnormalities, mental retardation and the search for genes in bipolar disorder and schizophrenia.

Authors:  D H R Blackwood; T Thiagarajah; P Malloy; B S Pickard; W J Muir
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.